| Cash Flow | 2025-09-30 |
|---|---|
| Net income | 229,585 |
| Provision for credit losses | 44,000 |
| Depreciation and amortization | 36,291 |
| Net loss on available-for-sale debt securities | -1,886 |
| Debt and equity securities, unrealized gain (loss) | 2,265 |
| Sales/(purchases) of trading securities, net | 2,219 |
| Stock-based compensation expense | 28,614 |
| Proceeds from sales and repayments of loans held for sale | 0 |
| Accrued interest receivable and other assets | 39,949 |
| Accrued interest payable and other liabilities | -66,283 |
| Net cash provided by operating activities | 229,660 |
| Purchases of available-for-sale debt securities | 843,190 |
| Proceeds from sales of available-for-sale debt securities | 280,402 |
| Proceeds from maturities, redemptions and pay-downs of available-for-sale debt securities | 385,694 |
| Proceeds from maturities, redemptions and pay-downs of held-to-maturity debt securities | 55,555 |
| Sales/(purchases) of equity securities, net | 22,472 |
| Originations of loans held for investment, mortgage finance | 71,110,334 |
| Proceeds from pay-offs of loans held for investment, mortgage finance | 70,268,104 |
| Net increase in loans held for investment, excluding mortgage finance loans | 936,069 |
| Purchase of premises and equipment, net | 12,910 |
| Net cash used in investing activities | -1,890,276 |
| Net increase in deposits | 2,266,799 |
| Issuance of stock related to stock-based awards | 7,559 |
| Preferred stock dividends paid | 12,938 |
| Repurchase of common stock | 59,234 |
| Net decrease in short-term borrowings | -610,000 |
| Redemption of long-term debt | 40,435 |
| Net cash provided by financing activities | 1,536,633 |
| Net increase/(decrease) in cash and cash equivalents | -123,983 |
| Cash and cash equivalents at beginning of period | 3,188,808 |
| Cash and cash equivalents at end of period | 3,064,825 |
TEXAS CAPITAL BANCSHARES INC TX (TCBIO)
TEXAS CAPITAL BANCSHARES INC TX (TCBIO)